Drug distributor backs fiscal 2024 profit guidance despite end of contract that generated 16% of its revenue last year.
More Stories
Amentum to replace Bath & Body Works on S&P 500
The engineering and tech-services firm Amentum will replace home-goods and fragrance chain Bath & Body Works on the S&P 500...
Stock-market indicator with a near-perfect track record is flashing a ‘buy’ signal
One closely-watched stock-market indicator is flashing a bright-red buy signal as more companies’ shares join the rally.
Investors see risks that the inflation battle isn’t over yet
Concerns that inflation might not be so easily defeated are starting to creep back into financial markets
China stock-market jump may be ‘tradable rally’ — but approach with caution
Chinese stocks and the exchange-traded funds that track them surged Tuesday after Beijing announced the biggest stimulus package since the...
How Caroline Ellison almost avoided prison in the criminal collapse of FTX
Prosecutors say Ellison proved essential in unraveling the theft of $8 billion in customer deposits and sending Sam Bankman-Fried to...
KB Home saw better demand for its homes as mortgage rates dropped
That message of optimism was not resonating with investors late Tuesday.